Barclays PLC Milestone Pharmaceuticals Inc. Call Options Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
44Shares Held
28.6MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$9.15 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.99 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5.11 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.89 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$3.79 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $55.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...